SterisMEX:STE N 90 Pretax Margin % is 19.17% as of Mar. 2026, which is 36% above its 10-year median of 14.13. GuruFocus rates MEX:STE N with a GF Score™ of 90/100 and a GF Value™ of MXN4,960.30. The stock has 1 warning sign investors should review. Among 817 Medical Devices & Instruments companies, Steris ranks better than 81.52% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Steris's Pre-Tax Income for the
three
months ended in Mar. 2026 was MXN5,491 Mil. Steris's Revenue for the
three
months ended in Mar. 2026 was MXN28,643 Mil. Therefore, Steris's pretax margin for the quarter that ended in Mar. 2026 was 19.17%.
The historical rank and industry rank for Steris's Pretax Margin % or its related term are showing as below:
MEX:STE N'
s Pretax Margin % Range Over the Past 10 Years
Min: 7.07 Med: 14.13 Max: 17.64
Current: 17.64
MEX:STE N's Pretax Margin % is ranked better than 81.52% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.43
vs MEX:STE N: 17.64
Steris (MEX:STE N) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Steris Pretax Margin % Related Terms
Steris Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Steris's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:STE N vs ZBH, GEHC, DXCM: Pretax Margin % Comparison
For the Medical Devices subindustry, Steris's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Steris Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Steris's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Steris's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Steris (MEX:STE N) has a Pretax Margin % of 19.17% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Steris and its competitors. This is 36% above median its historical median of 14.13. Over the past decade, Steris' Pretax Margin % has ranged from 7.07 to 17.64. According to the industry distribution chart, Steris ranks #151 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 18.5%.
Is Steris' Pretax Margin % too high?
Steris' current Pretax Margin % of 19.17% is 36% above median its 10-year median of 14.13. Over the past 10 years, this metric has ranged from a low of 7.07 to a high of 17.64. The Medical Devices & Instruments industry median Pretax Margin % is 2.43. Steris' value of 19.17% is 688.9% above this industry median. Based on the distribution chart, Steris ranks #151 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Steris has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Steris' Pretax Margin % compare to ZBH and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Steris ranks #151 out of 817 companies for Pretax Margin %. This places Steris in the top 19% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 2.43. Steris' value of 19.17% is 688.9% above this benchmark. Historically, Steris' own Pretax Margin % has ranged from 7.07 to 17.64 over the past decade. While the company's 10-year median is 14.13 vs. the industry median of 2.43, Steris has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.43, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Steris's current Pretax Margin % of 19.17% is 688.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Steris and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Steris's current Pretax Margin % is 19.17%, which is 36% above median its own 10-year median of 14.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steris stock overvalued right now?
Steris (MEX:STE N) has a current Pretax Margin % of 19.17%. The stock's GF Value™ is MXN4,960.30, compared to a current price of MXN3,824.43 — trading 22.9% below its estimated fair value. The current Pretax Margin % is 19.17%, which is 36% above median its 10-year median of 14.13 and 688.9% above the Medical Devices & Instruments industry median of 2.43. Steris' overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Steris (MEX:STE N), the current Pretax Margin % is 19.17% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Steris (MEX:STE N) Overvalued in 2026?
Based on GuruFocus' analysis, Steris stock appears to be undervalued.
The current stock price of MXN3,824.43 is trading 22.9% below its estimated GF Value™ of MXN4,960.30.
Key valuation signals for MEX:STE N:
Pretax Margin %: 19.17% (36% above median its 10-year median of 14.13)
GF Value™: MXN4,960.30 vs. price of MXN3,824.43 (22.9% below fair value)
Industry Position: 688.9% above the Medical Devices & Instruments median (#151 of 817)
No single metric tells the full story. See the MEX:STE N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
90GF Score
Get the complete analysis for MEX:STE N
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:STE N has been successfully added to your 
